Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study

被引:5
作者
Kasudhan, Kripa Shanker [1 ]
Patil, Amol N. [1 ]
Jandial, Aditya [2 ]
Khadwal, Alka [2 ]
Prakash, Gaurav [2 ]
Jain, Arihant [2 ]
Bhurani, Dinesh [3 ]
Ahmed, Rayaz [3 ]
Agrawal, Narendra [3 ]
Singh, Reema [3 ]
Sachdeva, Man Updesh Singh [4 ]
Varma, Neelam [4 ]
Das, Reena [4 ]
Verma Attri, Savita [5 ]
Malhotra, Samir [1 ]
Majhail, Navneet S. [6 ]
Malhotra, Pankaj [2 ]
Lad, Deepesh P. [2 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Clin Pharmacol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India
[3] Rajiv Gandhi Canc Inst & Res Ctr, Dept Hematooncol, New Delhi, India
[4] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh, India
[5] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh, India
[6] Cleveland Clin, Dept Hematol Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA
关键词
PTCy; pharmacokinetics; CEPM; GVHD; haplo-HCT; VERSUS-HOST-DISEASE; DRUG-METABOLIZING-ENZYMES; POLYMORPHISMS; SURVIVAL; GVHD; TOXICITY; REGIMEN; RELAPSE; PLASMA;
D O I
10.1080/10428194.2022.2087067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pharmacokinetics of cyclophosphamide has been explored to optimize conditioning dosing. We hypothesized that post-transplant cyclophosphamide (PTCy) metabolite carboxy-ethyl phosphoramide mustard (CEPM) pharmacokinetics might impact haploidentical transplantation (haplo-HCT) outcomes. CEPM area under the curve (AUC(0-48)) was determined by eleven sampling timepoints on day +3/+4 using LC-MS/MS. The median CEPM AUC(0-48) in a cohort of 30 patients was 14.2 (14) mg center dot hr/L. The incidence of severe chronic graft-versus-host disease (GVHD) (73% vs. 11%, p = 0.02), and GVHD-/relapse-free survival (GRFS) was significantly inferior in the CEPM AUC(0-48) < 14 mg center dot hr/L group (54 days vs. 344 days, p = 0.02). There was, however, no difference in grade III-IV acute GVHD (38% vs. 14%, p = 0.12) and overall survival (295 days vs. not reached, p = 0.2). CEPM AUC(0-48,) is associated with severe chronic GVHD and GRFS post-haplo-HCT in this exploratory study. There is scope for personalizing day + 4 PTCy dose based on day + 3 CEPM AUC(0-8).
引用
收藏
页码:2679 / 2685
页数:7
相关论文
共 50 条
[21]   Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation [J].
Koh, Jeong Suk ;
Lee, Myung-Won ;
Pham, Thi Thuy Duong ;
Heo, Bu Yeon ;
Choi, Suyoung ;
Lee, Sang-Woo ;
Seo, Wonhyoung ;
Kang, Sora ;
Lee, Seul Bi ;
Kim, Chul Hee ;
Ryu, Hyewon ;
Eun, Hyuk Soo ;
Lee, Hyo-Jin ;
Yun, Hwan-Jung ;
Jo, Deog-Yeon ;
Song, Ik-Chan .
BLOOD RESEARCH, 2025, 60 (01)
[22]   Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia [J].
Medina, Diego ;
Orlando Castro, Jhonier ;
Esteban Castro, David ;
Beltran, Estefania ;
Manzi, Eliana ;
Antonio Franco, Alexis ;
Olaya, Manuela .
BIOMEDICA, 2024, 44 :118-130
[23]   Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide [J].
Mariotti, Jacopo ;
Raiola, Anna Maria ;
Evangelista, Andrea ;
Harbi, Samia ;
Patriarca, Francesca ;
Carella, Michele Angelo ;
Martino, Massimo ;
Risitano, Antonio ;
Busca, Alessandro ;
Giaccone, Luisa ;
Brunello, Lucia ;
Merla, Emanuela ;
Savino, Lucia ;
Loteta, Barbara ;
Console, Giuseppe ;
Fanin, Renato ;
Sperotto, Alessandra ;
Marano, Luana ;
Marotta, Serena ;
Frieri, Camilla ;
Sica, Simona ;
Chiusolo, Patrizia ;
Chabannon, Christian ;
Furst, Sabine ;
Santoro, Armando ;
Bacigalupo, Andrea ;
Bruno, Benedetto ;
Blaise, Didier ;
Mavilio, Domenico ;
Bramanti, Stefania ;
Devillier, Raynier ;
Angelucci, Emanuele ;
Castagna, Luca .
BONE MARROW TRANSPLANTATION, 2022, 57 (12) :1758-1764
[24]   Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide [J].
Mehta, Rohtesh S. ;
Saliba, Rima M. ;
Alsfeld, Leonard C. ;
Jorgensen, Jeffrey L. ;
Wang, Sa A. ;
Anderlini, Paolo ;
Al-Atrash, Gheath ;
Bashir, Qaiser ;
Ciurea, Stefan O. ;
Hosing, Chitra M. ;
Im, Jin S. ;
Kebriaei, Partow ;
Khouri, Issa ;
Marin, David ;
Nieto, Yago ;
Olson, Amanda ;
Oran, Betul ;
Popat, Uday R. ;
Qazilbash, Muzaffar H. ;
Ramdial, Jeremy ;
Rondon, Gabriela ;
Saini, Neeraj ;
Srour, Samer A. ;
Rezvani, Katayoun ;
Shpall, Elizabeth J. ;
Champlin, Richard E. ;
Alousi, Amin M. .
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12) :1003.e1-1003.e13
[25]   Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation [J].
Dulery, Remy ;
Malard, Florent ;
Brissot, Eolia ;
Banet, Anne ;
Sestili, Simona ;
Belhocine, Ramdane ;
Calabro, Martina ;
van de Wyngaert, Zoe ;
Bonnin, Agnes ;
Ledraa, Tounes ;
Legrand, Ollivier ;
Labopin, Myriam ;
Capderou, Elodie ;
Cohen, Ariel ;
Ederhy, Stephane ;
Mohty, Mohamad .
BONE MARROW TRANSPLANTATION, 2023, 58 (11) :1215-1222
[26]   Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma [J].
Nakaya, Yosuke ;
Nakamae, Hirohisa ;
Nishikubo, Masashi ;
Kondo, Eisei ;
Fukuda, Takahiro ;
Hiramoto, Nobuhiro ;
Mori, Yasuo ;
Nagafuji, Koji ;
Eto, Tetsuya ;
Onishi, Yasushi ;
Uchida, Naoyuki ;
Ishikawa, Jun ;
Matsuoka, Ken-ichi ;
Yui, Shunsuke ;
Takase, Ken ;
Kawakita, Toshiro ;
Kanda, Junya ;
Ichinohe, Tatsuo ;
Atsuta, Yoshiko ;
Kako, Shinichi .
BONE MARROW TRANSPLANTATION, 2024, 59 (05) :630-636
[27]   Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission [J].
Nagler, Arnon ;
Labopin, Myriam ;
Dholaria, Bhagirathbhai ;
Blaise, Didier ;
Bondarenko, Sergey ;
Vydra, Jan ;
Choi, Goda ;
Rovira, Montserrat ;
Remenyi, Peter ;
Meijer, Ellen ;
Bulabois, Claude Eric ;
Diez-Martin, J. L. ;
Yakoub-Agha, Ibrahim ;
Brissot, Eolia ;
Spyridonidis, Alexandros ;
Sanz, Jaime ;
Patel, Amit ;
Arat, Mutlu ;
Bazarbachi, Ali ;
Bug, Gesine ;
Savani, Bipin N. ;
Giebel, Sebastian ;
Ciceri, Fabio ;
Mohty, Mohamad .
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (06) :1169-1178
[28]   Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes [J].
Solh, Melhem M. ;
Dickhaus, Elizabeth ;
Solomon, Scott R. ;
Morris, Lawrence E. ;
Zhang, Xu ;
Holland, H. Kent ;
Bashey, Asad .
BONE MARROW TRANSPLANTATION, 2019, 54 (11) :1756-1763
[29]   Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide [J].
Nikoloudis, Alexander ;
Bauhofer, Anna ;
Griessl, Lena ;
Habermehl, Anke ;
Groiss, Christina ;
Binder, Michaela ;
Milanov, Robert ;
Bauer, Thomas ;
Buxhofer-Ausch, Veronika ;
Aichinger, Christoph ;
Hasengruber, Petra ;
Kaynak, Emine ;
Wipplinger, Dagmar ;
Strassl, Irene ;
Stiefel, Olga ;
Petzer, Andreas ;
Rumpold, Holger ;
Machherndl-Spandl, Sigrid ;
Weltermann, Ansgar ;
Clausen, Johannes .
CYTOTHERAPY, 2025, 27 (04) :457-464
[30]   Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia [J].
Bonfim, Carmem ;
Ribeiro, Lisandro ;
Nichele, Samantha ;
Loth, Gisele ;
Bitencourt, Marco ;
Koliski, Adriana ;
Kuwahara, Cilmara ;
Fabro, Ana Luiza ;
Pereira, Noemi F. ;
Pilonetto, Daniela ;
Thakar, Monica ;
Kiem, Hans-Peter ;
Page, Kristin ;
Fuchs, Ephraim J. ;
Eapen, Mary ;
Pasquini, Ricardo .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) :310-317